<DOC>
	<DOCNO>NCT02500017</DOCNO>
	<brief_summary>This 8-week randomized , double-blind , placebo-controlled , parallel , fixed-dose pilot clinical trial test effectiveness melatonin treatment versus placebo symptom Night Eating Syndrome ( NES ) . The investigator also look effect melatonin treatment weight , metabolic parameter sleep parameter individual NES .</brief_summary>
	<brief_title>Melatonin Treatment Night-Eating Syndrome</brief_title>
	<detailed_description>Night Eating Syndrome ( NES ) unique disorder characterize delayed pattern food intake recurrent episode food consumption occur even meal and/or nocturnal awakening . Diagnostic criterion NES include : ( 1 ) recurrent episode night eating , manifest eat awaken sleep excessive food consumption follow even meal , ( 2 ) awareness eat episode , ( 3 ) significant distress impairment cause disorder . Exclusion criteria binge-eating disorder another mental disorder , well medical disorder medication might well explain disordered eating pattern . NES also common among patient insomnia , eat disorder , psychiatric disorder . 100 participant night eat syndrome recruit general population . They randomize either commercially available rapid-release formulation melatonin ( 5 mg ) match placebo capsule , administer day total 8 week . Participants attend screen appointment , baseline assessment additional research assessment visit every week 8 week .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>1 . 18 65 year age 2 . English speak 3 . Meet DSMV ( Diagnostic Statistical Manual version 5 ) criterion Night Eating Syndrome ( NES ) 1 . Unable provide inform consent 2 . Presence alcohol/substance dependence 3 . Presence eat disorder Binge Eating Disorder , Anorexia Nervosa . 4 . Significant uncontrolled systemic illness ( e.g . chronic renal failure , chronic liver disease , poorly control diabetes , poorly control congestive heart failure , chronic infectious disease , chronic autoimmune disease ) 5 . Women pregnant breastfeed 6 . Allergy hypersensitivity melatonin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>